Quantbot Technologies’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,267
| Closed | -$50.8K | – | 1647 |
|
|
2024
Q3 | $50.8K | Buy |
+1,267
| New | +$59K | ﹤0.01% | 1288 |
|
|
2024
Q2 | – | Sell |
-4,284
| Closed | -$186K | – | 1667 |
|
|
2024
Q1 | $186K | Sell |
4,284
-8,419
| -66% | -$401K | 0.01% | 1023 |
|
|
2023
Q4 | $643K | Buy |
12,703
+12,503
| +6,252% | +$599K | 0.04% | 640 |
|
|
2023
Q3 | $9.07K | Hold |
200
| – | – | ﹤0.01% | 1419 |
|
|
2023
Q2 | $8.21K | Buy |
+200
| New | +$7.68K | ﹤0.01% | 1472 |
|
|
2022
Q4 | – | Sell |
-8,106
| Closed | -$358K | – | 1873 |
|
|
2022
Q3 | $358K | Buy |
8,106
+6,906
| +576% | +$291K | 0.03% | 690 |
|
|
2022
Q2 | $44K | Buy |
+1,200
| New | +$45.3K | ﹤0.01% | 1326 |
|
|
2022
Q1 | – | Sell |
-5,076
| Closed | -$154K | – | 1832 |
|
|
2021
Q4 | $154K | Buy |
+5,076
| New | +$160K | 0.01% | 783 |
|
|
2021
Q1 | – | Sell |
-648
| Closed | -$36K | – | 1575 |
|
|
2020
Q4 | $36K | Buy |
648
+348
| +116% | +$17.3K | ﹤0.01% | 918 |
|
|
2020
Q3 | $14K | Sell |
300
-970
| -76% | -$53.9K | ﹤0.01% | 1060 |
|
|
2020
Q2 | $74K | Buy |
1,270
+952
| +299% | +$53K | 0.01% | 637 |
|
|
2020
Q1 | $15K | Buy |
+318
| New | +$17.7K | 0.01% | 634 |
|
|
2019
Q4 | – | Sell |
-797
| Closed | -$47K | – | 1398 |
|
|
2019
Q3 | $47K | Sell |
797
-494
| -38% | -$32.2K | ﹤0.01% | 979 |
|
|
2019
Q2 | $82K | Buy |
+1,291
| New | +$91.3K | 0.01% | 795 |
|
|
2018
Q1 | – | Sell |
-4,115
| Closed | -$206K | – | 1349 |
|
|
2017
Q4 | $206K | Sell |
4,115
-680
| -14% | -$37.3K | 0.02% | 695 |
|
|
2017
Q3 | $243K | Buy |
+4,795
| New | +$251K | 0.02% | 664 |
|
|
2017
Q1 | – | Sell |
-2,191
| Closed | -$104K | – | 1266 |
|
|
2016
Q4 | $104K | Buy |
+2,191
| New | +$86.7K | 0.01% | 702 |
|
|
2016
Q1 | – | Sell |
-6,200
| Closed | -$383K | – | 1269 |
|
|
2015
Q4 | $383K | Buy |
+6,200
| New | +$335K | 0.07% | 311 |
|
|
2015
Q3 | – | Sell |
-2,618
| Closed | -$150K | – | 1299 |
|
|
2015
Q2 | $150K | Sell |
2,618
-6,506
| -71% | -$414K | 0.03% | 526 |
|
|
2015
Q1 | $580K | Buy |
+9,124
| New | +$619K | 0.14% | 185 |
|
|
2014
Q4 | – | Sell |
-9,453
| Closed | -$367K | – | 1257 |
|
|
2014
Q3 | $367K | Buy |
9,453
+1,140
| +14% | +$40.4K | 0.05% | 489 |
|
|
2014
Q2 | $286K | Buy |
+8,313
| New | +$262K | 0.05% | 465 |
|
|
2013
Q4 | – | Sell |
-400
| Closed | -$15K | – | 1074 |
|
|
2013
Q3 | $15K | Buy |
+400
| New | +$11.9K | 0.01% | 670 |
|
Other funds holding IONS
BG
TBC
Quantbot Technologies's IONS Position: Q4 2024 in Review
Quantbot Technologies sold out of Ionis Pharmaceuticals (IONS) in Q4 2024, closing a stake of 1,267 shares — an estimated $50.8K sold.
Quantbot Technologies first reported a position in IONS in Q3 2013 and held it in 23 quarters. The position peaked at $643K in Q4 2023. 354 funds tracked by Wall St. Rank hold IONS as of Q4 2024.
- Quantbot Technologies reported no remaining Ionis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
- Quantbot Technologies sold 1,267 Ionis Pharmaceuticals shares in Q4 2024, an estimated $50.8K.
- Quantbot Technologies first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 23 quarters.
- Quantbot Technologies's Ionis Pharmaceuticals position peaked at $643K in Q4 2023.
- 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2024.
Based on Quantbot Technologies's 13F filing for Q4 2024, filed 11 Feb 2025.